Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Medical Hemostatic Agents market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Medical Hemostatic Agentsmarket, defines the market attractiveness level of Medical Hemostatic Agents market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Medical Hemostatic Agents industry, describes the types of Medical Hemostatic Agents market, the applications of major players and the market size, and deeply analyzes the current situation of the global Medical Hemostatic Agents market and the development prospects and opportunities of Medical Hemostatic Agents industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Medical Hemostatic Agents market in Chapter 13.
By Player:
Gelita Medical
CryoLife
Z-Medica
B Braun Melsungen
Biom’Up SAS
Advanced Medical Solutions
BioCer Entwicklungs
Anika Therapeutics
Marine Polymer Technologies
Vascular Solutions
Ethicon
The Medicines Company
Integra LifeSciences
Equimedical
C R Bard
Pfizer
Baxter International
By Type:
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
By End-User:
Hospitals
Surgical Centers
Clnics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Medical Hemostatic Agents Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Medical Hemostatic Agents Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Medical Hemostatic Agents Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Medical Hemostatic Agents Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Medical Hemostatic Agents Market Analysis and Outlook to 2022
-
7.1 Global Medical Hemostatic Agents Consumption (2017-2022)
-
7.2 United States Medical Hemostatic Agents Consumption (2017-2022)
-
7.3 Europe Medical Hemostatic Agents Consumption (2017-2022)
-
7.4 China Medical Hemostatic Agents Consumption (2017-2022)
-
7.5 Japan Medical Hemostatic Agents Consumption (2017-2022)
-
7.6 India Medical Hemostatic Agents Consumption (2017-2022)
-
7.7 South Korea Medical Hemostatic Agents Consumption (2017-2022)
8 Region and Country-wise Medical Hemostatic Agents Market Analysis and Outlook to 2028
-
8.1 Global Medical Hemostatic Agents Consumption Forecast (2022-2028)
-
8.2 United States Medical Hemostatic Agents Consumption Forecast (2022-2028)
-
8.3 Europe Medical Hemostatic Agents Consumption Forecast (2022-2028)
-
8.4 China Medical Hemostatic Agents Consumption Forecast (2022-2028)
-
8.5 Japan Medical Hemostatic Agents Consumption Forecast (2022-2028)
-
8.6 India Medical Hemostatic Agents Consumption Forecast (2022-2028)
-
8.7 South Korea Medical Hemostatic Agents Consumption Forecast (2022-2028)
9 Global Medical Hemostatic Agents Market Outlook by Types and Applications to 2022
-
9.1 Global Medical Hemostatic Agents Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gelation Sponge Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oxidized Regenerated Cellulose Based Hemostats Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Medical Hemostatic Agents Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clnics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Medical Hemostatic Agents Market Outlook by Types and Applications to 2028
-
10.1 Global Medical Hemostatic Agents Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Gelation Sponge Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oxidized Regenerated Cellulose Based Hemostats Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Medical Hemostatic Agents Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clnics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Medical Hemostatic Agents Import and Export Analysis (Top 5 Countries)
-
11.1 Global Medical Hemostatic Agents Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Medical Hemostatic Agents Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Medical Hemostatic Agents Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Medical Hemostatic Agents Market Competitive Analysis
-
14.1 Gelita Medical
-
14.1.1 Gelita Medical Company Details
-
14.1.2 Gelita Medical Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gelita Medical Medical Hemostatic Agents Product and Service
-
14.2 CryoLife
-
14.2.1 CryoLife Company Details
-
14.2.2 CryoLife Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CryoLife Medical Hemostatic Agents Product and Service
-
14.3 Z-Medica
-
14.3.1 Z-Medica Company Details
-
14.3.2 Z-Medica Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Z-Medica Medical Hemostatic Agents Product and Service
-
14.4 B Braun Melsungen
-
14.4.1 B Braun Melsungen Company Details
-
14.4.2 B Braun Melsungen Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 B Braun Melsungen Medical Hemostatic Agents Product and Service
-
14.5 Biom’Up SAS
-
14.5.1 Biom’Up SAS Company Details
-
14.5.2 Biom’Up SAS Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biom’Up SAS Medical Hemostatic Agents Product and Service
-
14.6 Advanced Medical Solutions
-
14.6.1 Advanced Medical Solutions Company Details
-
14.6.2 Advanced Medical Solutions Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Advanced Medical Solutions Medical Hemostatic Agents Product and Service
-
14.7 BioCer Entwicklungs
-
14.7.1 BioCer Entwicklungs Company Details
-
14.7.2 BioCer Entwicklungs Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 BioCer Entwicklungs Medical Hemostatic Agents Product and Service
-
14.8 Anika Therapeutics
-
14.8.1 Anika Therapeutics Company Details
-
14.8.2 Anika Therapeutics Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Anika Therapeutics Medical Hemostatic Agents Product and Service
-
14.9 Marine Polymer Technologies
-
14.9.1 Marine Polymer Technologies Company Details
-
14.9.2 Marine Polymer Technologies Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Marine Polymer Technologies Medical Hemostatic Agents Product and Service
-
14.10 Vascular Solutions
-
14.10.1 Vascular Solutions Company Details
-
14.10.2 Vascular Solutions Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Vascular Solutions Medical Hemostatic Agents Product and Service
-
14.11 Ethicon
-
14.11.1 Ethicon Company Details
-
14.11.2 Ethicon Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Ethicon Medical Hemostatic Agents Product and Service
-
14.12 The Medicines Company
-
14.12.1 The Medicines Company Company Details
-
14.12.2 The Medicines Company Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 The Medicines Company Medical Hemostatic Agents Product and Service
-
14.13 Integra LifeSciences
-
14.13.1 Integra LifeSciences Company Details
-
14.13.2 Integra LifeSciences Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Integra LifeSciences Medical Hemostatic Agents Product and Service
-
14.14 Equimedical
-
14.14.1 Equimedical Company Details
-
14.14.2 Equimedical Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Equimedical Medical Hemostatic Agents Product and Service
-
14.15 C R Bard
-
14.15.1 C R Bard Company Details
-
14.15.2 C R Bard Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 C R Bard Medical Hemostatic Agents Product and Service
-
14.16 Pfizer
-
14.16.1 Pfizer Company Details
-
14.16.2 Pfizer Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Pfizer Medical Hemostatic Agents Product and Service
-
14.17 Baxter International
-
14.17.1 Baxter International Company Details
-
14.17.2 Baxter International Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Baxter International Medical Hemostatic Agents Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Medical Hemostatic Agents
-
Figure Medical Hemostatic Agents Picture
-
Table Global Medical Hemostatic Agents Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Medical Hemostatic Agents Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Medical Hemostatic Agents Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Medical Hemostatic Agents Consumption by Country (2017-2022)
-
Figure United States Medical Hemostatic Agents Consumption and Growth Rate (2017-2022)
-
Table Europe Medical Hemostatic Agents Consumption and Growth Rate (2017-2022)
-
Figure China Medical Hemostatic Agents Consumption and Growth Rate (2017-2022)
-
Figure Japan Medical Hemostatic Agents Consumption and Growth Rate (2017-2022)
-
Figure India Medical Hemostatic Agents Consumption and Growth Rate (2017-2022)
-
Figure South Korea Medical Hemostatic Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Hemostatic Agents Consumption Forecast by Country (2022-2028)
-
Figure United States Medical Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Medical Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Medical Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Medical Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Medical Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Medical Hemostatic Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gelation Sponge Consumption and Growth Rate (2017-2022)
-
Figure Global Oxidized Regenerated Cellulose Based Hemostats Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Clnics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Gelation Sponge Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oxidized Regenerated Cellulose Based Hemostats Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clnics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Medical Hemostatic Agents Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Medical Hemostatic Agents Export by Region (Top 5 Countries) (2017-2028)
-
Table Gelita Medical (Foundation Year, Company Profile and etc.)
-
Table Gelita Medical Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gelita Medical Medical Hemostatic Agents Product and Service
-
Table CryoLife (Foundation Year, Company Profile and etc.)
-
Table CryoLife Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table CryoLife Medical Hemostatic Agents Product and Service
-
Table Z-Medica (Foundation Year, Company Profile and etc.)
-
Table Z-Medica Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Z-Medica Medical Hemostatic Agents Product and Service
-
Table B Braun Melsungen (Foundation Year, Company Profile and etc.)
-
Table B Braun Melsungen Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table B Braun Melsungen Medical Hemostatic Agents Product and Service
-
Table Biom’Up SAS (Foundation Year, Company Profile and etc.)
-
Table Biom’Up SAS Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biom’Up SAS Medical Hemostatic Agents Product and Service
-
Table Advanced Medical Solutions (Foundation Year, Company Profile and etc.)
-
Table Advanced Medical Solutions Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advanced Medical Solutions Medical Hemostatic Agents Product and Service
-
Table BioCer Entwicklungs (Foundation Year, Company Profile and etc.)
-
Table BioCer Entwicklungs Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCer Entwicklungs Medical Hemostatic Agents Product and Service
-
Table Anika Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Anika Therapeutics Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anika Therapeutics Medical Hemostatic Agents Product and Service
-
Table Marine Polymer Technologies (Foundation Year, Company Profile and etc.)
-
Table Marine Polymer Technologies Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marine Polymer Technologies Medical Hemostatic Agents Product and Service
-
Table Vascular Solutions (Foundation Year, Company Profile and etc.)
-
Table Vascular Solutions Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vascular Solutions Medical Hemostatic Agents Product and Service
-
Table Ethicon (Foundation Year, Company Profile and etc.)
-
Table Ethicon Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ethicon Medical Hemostatic Agents Product and Service
-
Table The Medicines Company (Foundation Year, Company Profile and etc.)
-
Table The Medicines Company Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Medicines Company Medical Hemostatic Agents Product and Service
-
Table Integra LifeSciences (Foundation Year, Company Profile and etc.)
-
Table Integra LifeSciences Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Integra LifeSciences Medical Hemostatic Agents Product and Service
-
Table Equimedical (Foundation Year, Company Profile and etc.)
-
Table Equimedical Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Equimedical Medical Hemostatic Agents Product and Service
-
Table C R Bard (Foundation Year, Company Profile and etc.)
-
Table C R Bard Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table C R Bard Medical Hemostatic Agents Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Medical Hemostatic Agents Product and Service
-
Table Baxter International (Foundation Year, Company Profile and etc.)
-
Table Baxter International Medical Hemostatic Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Medical Hemostatic Agents Product and Service
-
